Vimarsana
Biggest News Aggregation in the World

Page 40 - Term Fund News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Term Fund. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Term Fund Today - Breaking & Trending Today

Blackstone Strategic Credit 2027 Term Fund (NYSE:BGB) Increases Dividend to $0.09 Per Share - Vimarsana News

Blackstone Strategic Credit 2027 Term Fund (NYSE:BGB) Increases Dividend to $0.09 Per Share

Blackstone Strategic Credit 2027 Term Fund (NYSE:BGB – Get Rating) declared a monthly dividend on Monday, June 12th, Zacks reports. Investors of record on Friday, June 23rd will be given a dividend of 0.094 per share on Friday, June 30th. This represents a $1.13 dividend on an annualized basis and a dividend yield of 10.62%. […]

Blackstone Strategic Credit 2027 Term Fund (NYSE:BGB) Plans Dividend Increase – $0.09 Per Share - Vimarsana News

Blackstone Strategic Credit 2027 Term Fund (NYSE:BGB) Plans Dividend Increase – $0.09 Per Share

Blackstone Strategic Credit 2027 Term Fund (NYSE:BGB – Get Rating) declared a monthly dividend on Monday, June 12th, Zacks reports. Investors of record on Friday, June 23rd will be given a dividend of 0.094 per share on Friday, June 30th. This represents a $1.13 dividend on an annualized basis and a yield of 10.58%. The […]

Source: wkrb13.com
Alps Advisors Inc. Has $40.42 Million Stock Position in Denison Mines Corp. (NYSEAMERICAN:DNN) - Vimarsana News

Alps Advisors Inc. Has $40.42 Million Stock Position in Denison Mines Corp. (NYSEAMERICAN:DNN)

Blackstone Strategic Credit 2027 Term Fund (NYSE:BGB – Get Rating) announced a monthly dividend on Monday, June 12th, Zacks reports. Stockholders of record on Friday, June 23rd will be paid a dividend of 0.094 per share on Friday, June 30th. This represents a $1.13 annualized dividend and a dividend yield of 10.58%. The ex-dividend date […]

Virtus Convertible & Income 2024 Target Term Fund (NYSE:CBH) Short Interest Update - Vimarsana News

Virtus Convertible & Income 2024 Target Term Fund (NYSE:CBH) Short Interest Update

Virtus Convertible & Income 2024 Target Term Fund (NYSE:CBH – Get Rating) was the target of a large decrease in short interest in the month of May. As of May 31st, there was short interest totalling 2,900 shares, a decrease of 42.0% from the May 15th total of 5,000 shares. Based on an average trading […]

Ovid Therapeutics Bullish Outlook Strengthened By Positive 2-Year Open Label Trial Results - Vimarsana News

Ovid Therapeutics Bullish Outlook Strengthened By Positive 2-Year Open Label Trial Results

Ovid Therapeutics' TAK-935 has a high potential for positive Phase 3 clinical trial results for Dravet Syndrome and Lennox-Gastaut Syndrome. Find out why OVID stock is a Buy.